250 related articles for article (PubMed ID: 10403417)
1. In-vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata.
Defontaine A; Bouchara JP; Declerk P; Planchenault C; Chabasse D; Hallet JN
J Med Microbiol; 1999 Jul; 48(7):663-670. PubMed ID: 10403417
[TBL] [Abstract][Full Text] [Related]
2. In-vivo selection of an azole-resistant petite mutant of Candida glabrata.
Bouchara JP; Zouhair R; LE Boudouil S; Renier G; Filmon R; Chabasse D; Hallet JN; Defontaine A
J Med Microbiol; 2000 Nov; 49(11):977-984. PubMed ID: 11073151
[TBL] [Abstract][Full Text] [Related]
3. Candida glabrata: in vitro susceptibility of 84 isolates to eight antifungal agents.
Arias A; Arévalo MP; Andreu A; Rodríguez C; Sierra A
Chemotherapy; 1996; 42(2):107-11. PubMed ID: 8697885
[TBL] [Abstract][Full Text] [Related]
4. In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis.
Carrillo-Muñoz AJ; Guglietta A; Palacín C; Casals J; del Valle O; Guardià C; Rodríguez V; Quindós G
Chemotherapy; 2004 Dec; 50(6):308-13. PubMed ID: 15608448
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.
Hernández Molina JM; Llosá J; Martinez Brocal A; Ventosa A
Mycopathologia; 1992 Apr; 118(1):15-21. PubMed ID: 1406898
[TBL] [Abstract][Full Text] [Related]
6. Cross-Resistance of clinical isolates of Candida albicans and Candida glabrata to over-the-counter azoles used in the treatment of vaginitis.
Cross EW; Park S; Perlin DS
Microb Drug Resist; 2000; 6(2):155-61. PubMed ID: 10990271
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of azole resistance in petite mutants of Candida glabrata.
Brun S; Bergès T; Poupard P; Vauzelle-Moreau C; Renier G; Chabasse D; Bouchara JP
Antimicrob Agents Chemother; 2004 May; 48(5):1788-96. PubMed ID: 15105136
[TBL] [Abstract][Full Text] [Related]
8. [Comparative action of 8 azole derivatives against Candida albicans: fungistatic action and cytologic study by scanning electron microscopy].
Mallie M; Jouvert S; Bastide M; Montes B; Lebecq JC; Bastide JM
Pathol Biol (Paris); 1988 May; 36(5):575-80. PubMed ID: 3043361
[TBL] [Abstract][Full Text] [Related]
9. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
[TBL] [Abstract][Full Text] [Related]
11. Clinical applicability of antifungal susceptibility testing on non-Candida albicans species in hospitalized patients.
Wong-Beringera A; Hindler J; Brankovic L; Muehlbauer L; Steele-Moore L
Diagn Microbiol Infect Dis; 2001 Jan; 39(1):25-31. PubMed ID: 11173188
[TBL] [Abstract][Full Text] [Related]
12. Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole.
Borst A; Raimer MT; Warnock DW; Morrison CJ; Arthington-Skaggs BA
Antimicrob Agents Chemother; 2005 Feb; 49(2):783-7. PubMed ID: 15673768
[TBL] [Abstract][Full Text] [Related]
13. In-vitro antifungal activity of sertaconazole, bifonazole, ketoconazole, and miconazole against yeasts of the Candida genus.
Carrilo-Muñoz AJ; Tur C; Torres J
J Antimicrob Chemother; 1996 Apr; 37(4):815-9. PubMed ID: 8722548
[TBL] [Abstract][Full Text] [Related]
14. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
15. A Transcriptomics Approach To Unveiling the Mechanisms of
Cavalheiro M; Costa C; Silva-Dias A; Miranda IM; Wang C; Pais P; Pinto SN; Mil-Homens D; Sato-Okamoto M; Takahashi-Nakaguchi A; Silva RM; Mira NP; Fialho AM; Chibana H; Rodrigues AG; Butler G; Teixeira MC
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348666
[No Abstract] [Full Text] [Related]
16. Azole resistance in Candida.
Denning DW; Baily GG; Hood SV
Eur J Clin Microbiol Infect Dis; 1997 Apr; 16(4):261-80. PubMed ID: 9177959
[TBL] [Abstract][Full Text] [Related]
17. [In vitro resistance of Candida species to antifungal agents].
Banach-Piatkowska W; Kotłowski A; Humanowska J; Mayer L; Kowalczyk D
Wiad Parazytol; 2001; 47(4):811-6. PubMed ID: 16886432
[TBL] [Abstract][Full Text] [Related]
18. Relationships between respiration and susceptibility to azole antifungals in Candida glabrata.
Brun S; Aubry C; Lima O; Filmon R; Bergès T; Chabasse D; Bouchara JP
Antimicrob Agents Chemother; 2003 Mar; 47(3):847-53. PubMed ID: 12604511
[TBL] [Abstract][Full Text] [Related]
19. Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
Odds FC; Webster CE; Abbott AB
J Antimicrob Chemother; 1984 Aug; 14(2):105-14. PubMed ID: 6094418
[TBL] [Abstract][Full Text] [Related]
20. Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata.
Sanglard D; Ischer F; Bille J
Antimicrob Agents Chemother; 2001 Apr; 45(4):1174-83. PubMed ID: 11257032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
